Literature DB >> 22123572

[Severe lactic acidosis due to metformin: report of 3 cases].

Céline Roche1, André Nau, Eric Peytel, Jean-Luc Moalic, Manuela Oliver.   

Abstract

Metformin, an oral antidiabetic drug, is the sole representative of the biguanide class available in France. Because of its beneficial effects on weight and cardiovascular level, it represents the standard treatment for type 2 diabetic obese patients. Lactic acidosis associated with metformin is a rare but serious complication that can occur in these patients, particularly when intercurrent episode promotes the accumulation of this molecule. We report three cases in which the toxic origin of acidosis has been objectified by the plasma assay and intra-erythrocyte metformin. Curative treatment is based on renal replacement therapy, but the main treatment is preventive, requiring compliance with the cons-indications and rules of prescription of this drug.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22123572     DOI: 10.1684/abc.2011.0619

Source DB:  PubMed          Journal:  Ann Biol Clin (Paris)        ISSN: 0003-3898            Impact factor:   0.459


  3 in total

Review 1.  Therapeutic Concentrations of Metformin: A Systematic Review.

Authors:  Farshad Kajbaf; Marc E De Broe; Jean-Daniel Lalau
Journal:  Clin Pharmacokinet       Date:  2016-04       Impact factor: 6.447

2.  Metformin in the treatment of obese children and adolescents at risk of type 2 diabetes.

Authors:  Deborah L Kendall; Rakesh Amin; Peter E Clayton
Journal:  Paediatr Drugs       Date:  2014-02       Impact factor: 3.022

3.  Metformin and its clinical use: new insights for an old drug in clinical practice.

Authors:  Arrigo F G Cicero; Elisa Tartagni; Sibel Ertek
Journal:  Arch Med Sci       Date:  2012-11-07       Impact factor: 3.318

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.